Who invested in Genepoint Biological Technology?
Genepoint Biological Technology's investors include Northern Light Venture Capital.
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2023, from 1 source
Genepoint Biological Technology's investors include Northern Light Venture Capital.
Genepoint Biological Technology has raised $30M across 1 round since 2023.
Genepoint Biological Technology's most recent round was a Series D of $30M in Jan 2023.
Its most recent round, $30M in Jan 2023, is also its largest on record.
Genepoint Biological Technology's first round on record, in Jan 2023, was backed by Northern Light Venture Capital.
Genepoint Biological Technology's latest named round is a Series D, in Jan 2023.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.